top of page

S Gastrointestinal And Liver Disease 12th Edition Hot [work] Jun 2026

The 12th edition of this textbook features:

This latest edition is not merely an incremental update; it represents a significant transformation of a foundational text. It adapts to the rapidly changing medical landscape, welcomes a new generation of leadership, and integrates cutting-edge developments like artificial intelligence, making it a crucial resource for any GI specialist. This comprehensive guide explores everything you need to know about the 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease .

is scheduled for release in . This updated two-volume masterwork is led by a new senior editorial team consisting of Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox . Key Content Updates & New Chapters

Purchasing the physical set also unlocks the digital ecosystem. The allows clinicians to instantly search across the entire 2,560-page text via mobile devices, stream over 20 procedural videos, and access rolling monthly online updates to ensure the text never goes out of date. Target Audience and Clinical Utility s gastrointestinal and liver disease 12th edition hot

: Latest information on biologic agents and small molecules for Inflammatory Bowel Disease (IBD) and new treatments for viral hepatitis. Amazon.com Product Details

This edition is currently available for purchase at major retailers like and directly from Elsevier Evolve Amazon.com included in this new edition?

The 12th edition heavily features the integration of technology in clinical gastroenterology, highlighting how . The 12th edition of this textbook features: This

Real-time computer-aided polyp detection (CADe) during colonoscopies.

With the renaming of Fatty Liver Disease to MASH, the 12th edition provides the most current nomenclature and pharmacological pipelines for treating metabolic liver dysfunction. 3. Functional Disorders

The textbook includes new chapters detailing the . This section establishes long-term management frameworks for post-acute sequelae of COVID-19 (PASC) affecting gut motility, hepatic enzyme fluctuations, and the gut-brain axis. Comprehensive Section Breakdown Pathophysiology and Basic Science is scheduled for release in

Sleisenger and Fordtran's Gastrointestinal and Liver Disease

: Expanded coverage of the gut microbiome's role in local inflammation, metabolic signaling, and systemic immunity.

The 12th edition comes in multiple formats, and your choice matters.

The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease has been extensively revised and updated to reflect the latest scientific and clinical knowledge. Some of the key features of this edition include:

Many textbooks trickle out minor changes. Not this one. Here is the direct comparison that has residents and attendings scrambling to upgrade:

bottom of page